BRIBF (Brii Biosciences) Buyback Yield %: 2.74 (As of Jun. 29, 2026)


BRIBF Brii Biosciences Ltd BRIBF
34 GF Score
Price $0.15
! 1 Warning Sign
View Full Analysis

What is Brii Biosciences Buyback Yield %?

Brii Biosciences BRIBF 34 Buyback Yield % is 2.74 as of Jun. 29, 2026. GuruFocus rates BRIBF with a GF Score™ of 34/100. The stock has 1 warning sign investors should review. Among 742 Biotechnology companies, Brii Biosciences ranks better than 97.44% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Brii Biosciences's current buyback yield was 2.74%.

Brii Biosciences Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Brii Biosciences's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brii Biosciences Buyback Yield % Chart

Brii Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial 0.00 -0.14 0.08 0.03 1.79

Brii Biosciences Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 -0.01 0.02 1.50 1.86

BRIBF vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Brii Biosciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brii Biosciences Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Brii Biosciences's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Brii Biosciences's Buyback Yield % falls into.


BRIBF
34GF Score
Brii Biosciences Ltd BRIBF
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brii Biosciences Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Brii Biosciences's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-2.485 + 0.077) / 134.65095767
=1.79%

Brii Biosciences's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-2.485 + 0.077) / 134.65095767
=1.79%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 2.74 mean?
Brii Biosciences (BRIBF) has a Buyback Yield % of 2.74 as of Jun. 29, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Brii Biosciences and its competitors. According to the industry distribution chart, Brii Biosciences ranks #19 out of 742 companies in the Biotechnology industry, placing it in the top 2.6%.
Is Brii Biosciences' Buyback Yield % too high?
Brii Biosciences' current Buyback Yield % is 2.74. Based on the distribution chart, Brii Biosciences ranks #19 out of 742 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Brii Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Brii Biosciences' Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Brii Biosciences ranks #19 out of 742 companies for Buyback Yield %. This places Brii Biosciences in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Brii Biosciences and its competitors. Brii Biosciences's current Buyback Yield % is 2.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brii Biosciences stock overvalued right now?
Brii Biosciences (BRIBF) has a current Buyback Yield % of 2.74. The current Buyback Yield % is 2.74. Brii Biosciences' overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Brii Biosciences (BRIBF), the current Buyback Yield % is 2.74 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Brii Biosciences Business Description

Other Exchanges 02137:Hong Kong7SS:Germany
Address No. 1 North Yongtaizhuang Road, 3rd Floor, Building 7, Zhongguancun Dongsheng, International Science Park, Haidian District, Beijing, CHN, 100192
Brii Biosciences Ltd is a biotechnology company based in China and the United States. It is committed to developing advancing therapies for infectious diseases, such as HBV, HIV, MDR/XDR gram-negative infections, and other illnesses, such as CNS diseases, which have public health burdens in China and around the world. The company's pipeline of products includes more than 10 product candidates that focus on infectious diseases and mental illnesses.
34GF Score

Get the complete analysis for BRIBF

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price